L & S Advisors Inc Has $3.10 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

L & S Advisors Inc grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 6,092 shares of the healthcare conglomerate’s stock after acquiring an additional 1,441 shares during the period. L & S Advisors Inc’s holdings in UnitedHealth Group were worth $3,102,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Macroview Investment Management LLC raised its position in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $31,000. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group in the second quarter valued at $31,000. Finally, Signature Resources Capital Management LLC grew its holdings in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Robert W. Baird lifted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Monday. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Truist Financial boosted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Down 0.9 %

Shares of NYSE UNH opened at $589.16 on Tuesday. The stock has a market capitalization of $542.25 billion, a PE ratio of 36.01, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The business’s fifty day moving average price is $571.08 and its 200-day moving average price is $518.38. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $6.14 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.